BlackRock Institutional Trust’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
BA
BFA
BlackRock Institutional Trust's DGX Position: Q4 2016 in Review
BlackRock Institutional Trust increased its Quest Diagnostics (DGX) stake by 2.4% in Q4 2016, buying an estimated $8.99M and bringing the position to 4,370,095 shares worth $402M. The position accounts for 0.06% of the portfolio, ranked #317.
BlackRock Institutional Trust first reported a position in DGX in Q2 2013 and has held it in 15 quarters since. 597 funds tracked by Wall St. Rank hold DGX as of Q4 2016.
- BlackRock Institutional Trust held 4,370,095 shares of Quest Diagnostics worth $402M as of Q4 2016.
- BlackRock Institutional Trust bought 104,303 Quest Diagnostics shares in Q4 2016, an estimated $8.99M.
- Quest Diagnostics made up 0.06% of BlackRock Institutional Trust's portfolio in Q4 2016, its #317 holding.
- BlackRock Institutional Trust first reported a position in Quest Diagnostics in Q2 2013 and has held it in 15 quarters since.
- 597 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.